BB Biotech AG (BBAGF)
53.60
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
BB Biotech Net Income (Quarterly) : 570.82M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 570.82M |
| March 31, 2026 | -27.28M |
| December 31, 2025 | 590.18M |
| September 30, 2025 | 559.37M |
| June 30, 2025 | -121.23M |
| March 31, 2025 | -268.01M |
| December 31, 2024 | 67.99M |
| September 30, 2024 | -181.39M |
| June 30, 2024 | -96.28M |
| March 31, 2024 | 297.93M |
| December 31, 2023 | 122.93M |
| September 30, 2023 | -54.75M |
| June 30, 2023 | -14.99M |
| March 31, 2023 | -274.37M |
| December 31, 2022 | -36.46M |
| September 30, 2022 | 217.54M |
| June 30, 2022 | -241.79M |
| March 31, 2022 | -324.58M |
| December 31, 2021 | -592.17M |
| September 30, 2021 | -226.93M |
| June 30, 2021 | 141.05M |
| March 31, 2021 | 243.86M |
| December 31, 2020 | 735.40M |
| September 30, 2020 | -429.44M |
| June 30, 2020 | 1.224B |
| Date | Value |
|---|---|
| March 31, 2020 | -782.74M |
| December 31, 2019 | 510.40M |
| September 30, 2019 | -387.21M |
| June 30, 2019 | -334.96M |
| March 31, 2019 | 892.51M |
| December 31, 2018 | -645.53M |
| September 30, 2018 | 245.71M |
| June 30, 2018 | -100.06M |
| March 31, 2018 | 29.77M |
| December 31, 2017 | -157.62M |
| September 30, 2017 | 378.80M |
| June 30, 2017 | 105.01M |
| March 31, 2017 | 373.71M |
| December 31, 2016 | -24.22M |
| September 30, 2016 | 401.96M |
| June 30, 2016 | 36.64M |
| March 31, 2016 | -1.213B |
| December 31, 2015 | 516.01M |
| September 30, 2015 | -596.54M |
| June 30, 2015 | 358.17M |
| March 31, 2015 | 398.02M |
| December 31, 2014 | 753.24M |
| September 30, 2014 | 528.25M |
| June 30, 2014 | 219.84M |
| March 31, 2014 | 73.52M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| UBS Group AG | 2.811B |
| GAM Holding AG | -- |
| Julius Bär Gruppe AG | -- |
| Partners Group Holding AG | -- |
| Vontobel Holding AG | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 139.22M |
| Total Expenses (Quarterly) | -431.60M |
| EPS Diluted (Quarterly) | 10.35 |
| Enterprise Value | -857.62M |
| Earnings Yield | 57.38% |
| Operating Earnings Yield | 57.41% |
| Normalized Earnings Yield | 57.38 |